All In MedTech

Device Trial Radar · NCT04381767

EYE-SYNC Concussion Classification Study

Last checked: Nov 19, 2026Latest source record: Jun 25, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

1,303

Actual

Start

Dec 19, 2018

Primary completion

Mar 23, 2020

Study completion Jun 23, 2020

Sponsor

Lead sponsor
Sync-Think, Inc.Not on our public-company list
Sponsor type
Industry
First posted
May 11, 2020

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine the sensitivity and specificity of an aid in assessment of concussion based on eye-tracking, in comparison to a clinical reference standard appropriate for sport-related concussion evaluation.

Conditions

  • Concussion, Mild
  • Concussion; Eye
  • Concussion, Brain
  • Concussion, Severe
  • Brain Injuries
  • Concussion, Cerebral

Interventions

  • EYE-SYNCDevice

    Evaluation of oculomotor performance using visual presentation and eye tracking analysis

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. A change in metrics of eye movement that enable positive concussion detection using EYE-SYNC metricsTime frame: 3 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Sync-Think, Inc.

    Palo Alto, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.